genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Tech Exclusives
Nuclear Glycogen Linked to Non-Small Cell Lung Cancer
News
BioNTech Plans Pipeline, Platform Expansion with IPO Proceeds
News
Fight-or-Flight Response Shown to be Driven by Bone Hormone, Not Adrenaline
News
AI Improves Diagnosis of Head and Neck Cancers Using DNA Methylation
News
Gene Therapy Repairs Stroke Damage and Improves Motor Function
Insights
Insights
CRISPR-Chip Launched as “Genome Sensor”
Bioprocessing
Controlling Impurities in Cell Culture Media
Insights
10 Takeover Targets to Watch This Fall
Tech Exclusives
Going Viral: The Next Generation of AAV Vectors
Tech Exclusives
Looking Into a Crystal Ball
A-Lists
Insights
10 Takeover Targets to Watch This Fall
Insights
What the Top 10 Biopharma CEOs Are Making
Insights
Top 10 Companies Leveraging Gene Editing in 2019
Insights
Top 10 Young Companies in the Money, January–July 2019
August 2019 Vol. 39 No. 8
Top 10 Biopharma IPOs of January–June 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Tech Exclusives
Nuclear Glycogen Linked to Non-Small Cell Lung Cancer
Insights
CRISPR-Chip Launched as “Genome Sensor”
News
BioNTech Plans Pipeline, Platform Expansion with IPO Proceeds
News
AI Improves Diagnosis of Head and Neck Cancers Using DNA Methylation
Magazine
Tech Exclusives
Going Viral: The Next Generation of AAV Vectors
Tech Exclusives
Looking Into a Crystal Ball
Tech Exclusives
Liquid Biopsies Intensify Surveillance of ctDNA
Tech Exclusives
Drug–Drug Interaction Studies Look Beyond CYP Activity
Tech Exclusives
3D Bioprinting Makes the Imitation Matrix Real
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
eBooks
Breakthroughs in Immunotherapy
Upcoming Webinars
Pancreatic Cancer Therapeutic Target Visualized Using In Situ Hybridization
Upcoming Webinars
Bring Greater Efficiency to Your Biobank Lab
Upcoming Webinars
Reliable Single Cell Outgrowth: Dark Art or Science?
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Neurological Disorders
ALS
ALS
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
ALS
Is ALS More Genetically Driven than Once Thought?
ALS
Sanofi, Denali Launch $1B+ Alliance to Develop RIPK1 Inhibitors for Neurological, Inflammatory Diseases
ALS
Amyloids Shown to Also Play Beneficial Role in Developing Healthy Muscle Tissue
ALS
Axovant Licenses Benitec Gene Therapy Candidates for OPMD, Neurological Disorders
ALS
Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase II Trials in ALS, CMT
ALS
Neuraltus Weighs Future of Lead Candidate NP001 after Failure in Phase...
ALS
Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success
ALS
Novel Research Model Offers Hope to ALS and MS Patients
ALS
Hardening of the RNA Condensates May Solidify Neurodegeneration
ALS
Hope for ALS Patients Comes from New Understanding of RNA Metabolism...
ALS
CRISPR Screen Identifies Genetic Modifiers of ALS
ALS
CRISPR Human Knockout Screens Identify New Target for ALS
ALS
Studying Changing Neuron Size May Lead to New Therapies for Motor...
ALS
Proteomics Finding May Lead to Therapy Targeted at Cellular Pathway Linked...
ALS
Sangamo, Pfizer Partner on Gene Therapy for ALS, FTLD
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![The hnRNP A1B is expressed in the central nervous system and forms cytoplasmic aggregates in ALS patient neurons. [CRCHUM]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar19_2018_CRCHUM_hnRNPA1B2262381965-324x160.jpg "Hope for ALS Patients Comes from New Understanding of RNA Metabolism Misregulation")
![Flex Pharma cites unspecified “oral tolerability concerns” in halting Phase II trials of FLX-787 in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT). [© whitehoune / Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/170123090806_1_900x6009916143062-265x198.jpg "Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase II Trials in ALS, CMT")
